APA (7th ed.) Citation

S, U., IA, B., N, A., K, A. R., N, A., G, G., . . . SP, N. (2026). Radiolabeled fibroblast activation protein inhibitor PET/computed tomography imaging in invasive lobular breast cancer: A narrative review and research agenda. Nuclear medicine communications, 47(6), 612. https://doi.org/10.1097/MNM.0000000000002132

Chicago Style (17th ed.) Citation

S, Usmani, Burney IA, Ahmed N, Al Riyami K, Ahmad N, Gnanasegaran G, Al-Ibraheem A, Sheikh A, and Numani SP. "Radiolabeled Fibroblast Activation Protein Inhibitor PET/computed Tomography Imaging in Invasive Lobular Breast Cancer: A Narrative Review and Research Agenda." Nuclear Medicine Communications 47, no. 6 (2026): 612. https://doi.org/10.1097/MNM.0000000000002132.

MLA (9th ed.) Citation

S, Usmani, et al. "Radiolabeled Fibroblast Activation Protein Inhibitor PET/computed Tomography Imaging in Invasive Lobular Breast Cancer: A Narrative Review and Research Agenda." Nuclear Medicine Communications, vol. 47, no. 6, 2026, p. 612, https://doi.org/10.1097/MNM.0000000000002132.